Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Revenue

Esperion Therapeutics had revenue of $80.10M in the quarter ending March 31, 2026, with 23.25% growth. This brings the company's revenue in the last twelve months to $418.24M, up 61.13% year-over-year. In the year 2025, Esperion Therapeutics had annual revenue of $403.14M with 21.31% growth.

• Revenue (ttm): $418.24M
• Revenue Growth: +61.13%
• P/S Ratio: 1.93
• Revenue / Employee: $1,422,599
• Employees: 294
• Market Cap: 805.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	403.14M	70.82M	21.31%
Dec 31, 2024	332.31M	215.98M	185.66%
Dec 31, 2023	116.33M	40.86M	54.14%
Dec 31, 2022	75.48M	-2.97M	-3.79%
Dec 31, 2021	78.45M	-149.10M	-65.52%
Dec 31, 2020	227.55M	79.18M	53.37%
Dec 31, 2019	148.36M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: May 8, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error